5-5′-substituted indirubin-3′-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity - Choi, S J; Lee, J E; Jeong, S Y; Im, I; Lee, S D; Lee, E J; Lee, S K; Kwon, S M; Ahn, S G; Yoon, J H; Han, S Y; Kim, J I; Kim, Y C (J Med Chem, 2010)